agilon health, inc.
AGL
$86.39
$5.827.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -7.28% | 3.14% | -1.05% | -5.92% | -4.45% |
| Total Other Revenue | -34.17% | -22.73% | -10.85% | -7.42% | -8.10% |
| Total Revenue | -7.33% | 3.09% | -1.08% | -5.92% | -4.46% |
| Cost of Revenue | -8.54% | 6.37% | -0.80% | -0.22% | -3.09% |
| Gross Profit | 28.18% | -137.01% | -5.42% | -262.94% | -32.45% |
| SG&A Expenses | -26.46% | -1.92% | -15.51% | -18.30% | -11.59% |
| Depreciation & Amortization | -1.29% | 7.31% | 19.49% | 23.90% | 17.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.27% | 6.07% | -1.29% | -0.94% | -3.40% |
| Operating Income | 146.84% | -49.43% | 3.69% | -172.88% | -353.18% |
| Income Before Tax | 1,869.74% | -79.18% | 5.54% | -244.88% | -154.34% |
| Income Tax Expenses | -85.71% | -24.64% | 43.90% | -85.13% | 247.37% |
| Earnings from Continuing Operations | 1,684.53% | -77.47% | 5.35% | -240.39% | -158.15% |
| Earnings from Discontinued Operations | 35.71% | -100.00% | -- | -- | 250.85% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 303.86% | -78.54% | 6.30% | -240.17% | 299.74% |
| EBIT | 146.84% | -49.43% | 3.69% | -172.88% | -353.18% |
| EBITDA | 214.88% | -55.53% | 4.84% | -196.94% | -1,460.68% |
| EPS Basic | 301.87% | -77.44% | 6.95% | -238.05% | 297.81% |
| Normalized Basic EPS | 3,171.72% | -47.38% | 8.53% | -252.08% | -121.11% |
| EPS Diluted | 300.97% | -77.44% | 6.95% | -238.05% | 297.81% |
| Normalized Diluted EPS | 3,160.18% | -47.38% | 8.53% | -252.08% | -121.11% |
| Average Basic Shares Outstanding | 0.50% | 0.62% | 0.70% | 0.62% | 0.98% |
| Average Diluted Shares Outstanding | 0.88% | 0.62% | 0.70% | 0.62% | 0.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |